Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Frankfurt
24.01.25
08:05 Uhr
0,855 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,8450,88520:45
0,8450,88020:45

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:06China Medical System Holdings Ltd. (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K1073SHENZHEN, CHINA, Jan. 24, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January...
► Artikel lesen
13:42CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A COLLABORATION AGREEMENT FOR CLASS 1 INNOVATIVE DRUG MG-K10 HUMANIZED MONOCLONAL ANTIBODY ...1
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
08.01.China Medical System Holdings Ltd. (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type17SHENZHEN, CHINA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January...
► Artikel lesen
08.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT OF IMPROVED NEW DRUG ZUNVEYL FOR THE ...-
09.12.24China Medical System Holdings Ltd.: First Prescriptions for Innovative Drug Lumeblue Issued in China107SHENZHEN, CHINA, Dec. 08, 2024 (GLOBE NEWSWIRE) -- On 6 December, China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the first prescriptions for the innovative...
► Artikel lesen
02.12.24China Medical System Holdings Ltd. Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia133SHENZHEN, CHINA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 2 December...
► Artikel lesen
02.12.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT GAINING EXCLUSIVE COMMERCIALIZATION RIGHT OF CLASS 1 INNOVATIVE DRUG FOR THE TREATMENT OF GOUT ...1
27.11.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR INNOVATIVE DRUG DUAL AGONIST OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR/GLUCAGON ...-
05.11.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF RUXOLITINIB PHOSPHATE CREAM FOR VITILIGO APPROVED IN HONG KONG-
18.10.24China Medical System Holdings Ltd.: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area3SHENZHEN, CHINA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib...
► Artikel lesen
24.09.24China Medical System Holdings Ltd.: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China360SHENZHEN, CHINA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September...
► Artikel lesen
24.09.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR VITILIGO INDICATION OF RUXOLITINIB PHOSPHATE CREAM ACCEPTED IN CHINA1
30.08.24CMS (00867): INTERIM REPORT 20241
29.08.24Dividendenbekanntmachungen (29.08.2024)10.690 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABC-MART INC  JP3152740001  33 JPY  0,2055 EUR  ADASTRIA CO LTD  JP3856000009  35 JPY  0,218 EUR  AEON CO LTD  JP3388200002  20 JPY  0...
► Artikel lesen
16.08.24China Medical System Holdings Ltd. (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023211SHENZHEN, CHINA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady...
► Artikel lesen
15.08.24CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
15.08.24CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 20241
15.08.24CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024 AND RE-DESIGNATION OF DIRECTOR1
05.08.24China Medical System Holdings Ltd.: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China156SHENZHEN, CHINA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July...
► Artikel lesen
05.08.24CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR ADDITIONAL RHEUMATOID ARTHRITIS (RA) INDICATION OF METHOTREXATE INJECTION ...-
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1